Nitrile Powder Free Examination Glove, Blue Tested for Use with 32 Chemotherapy Drugs and Fentanyl Permeation Resistance Claim +1 more— 510(k) K260312

Substantially Equivalent

Gmp Medicare Sdn. Bhd.

FDA 510(k) clearance K260312 for Nitrile Powder Free Examination Glove, Blue Tested for Use with 32 Chemotherapy Drugs and Fentanyl Permeation Resistance Claim +1 more, Substantially Equivalent on 2026-09-08. Applicant: Gmp Medicare Sdn. Bhd.. Device class: 1.

Summary

Gmp Medicare's clearance covers two powder-free nitrile examination gloves under LZA, polymer patient examination gloves. The blue glove's name says it was tested for use with 32 chemotherapy drugs and carries a fentanyl permeation resistance claim. The violet blue glove's name lists 32 chemotherapy drugs, xylazine, fentanyl, and gastric acid.

Class I, 21 CFR 880.6250. General Hospital is both the classification panel and the review panel. It was a Special 510(k).

Gmp Medicare filed from Klang, Malaysia. The decision came 221 calendar days after receipt (January 30 to September 8, 2026).

Clearance details

Device name as filed
Nitrile Powder Free Examination Glove, Blue Tested for Use with 32 Chemotherapy Drugs and Fentanyl Permeation Resistance Claim; Nitrile Powder Free Examination Glove, Violet Blue Tested for Use with 32 Chemotherapy Drugs, Xylazine, Fentanyl & Gastric Acid
Applicant
Gmp Medicare Sdn. Bhd.
Product code
Product code LZA
Device class
Class 1
Regulation
21 CFR 880.6250
Advisory panel
General Hospital
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Special
Location
Klang, MY
Download summary PDFView on FDA.gov ↗

Recent devices under product code LZA

view all

More clearances from Gmp Medicare Sdn. Bhd.

view all

Adverse events under product code LZA

product code LZA
Other
1
Total
1

Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.